Safety of misoprostol as a cervical ripening agent in vaginal birth after cesarean section

Primary Care Update for Ob/Gyns

Volumn 8, Issue 6, 2001, Pages 244-247

  Nwachuku, Victor ^a   Sison, Antonio ^a   Quashie, Carlene ^a   Chau, Andrew ^a   Yeh, Sze Ya ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN;

COMPARATIVE STUDY; DELIVERY; DRUG SAFETY; FETUS HEART RATE; FETUS RISK; HEART ARRHYTHMIA; HUMAN; LABOR; MATERNAL CARE; MECONIUM; OUTCOMES RESEARCH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX RIPENING; UTERUS RUPTURE; WOUND DEHISCENCE;

EID: 0035168054     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(01)00089-0     Document Type: Article

References (12)

1. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol
2. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination
3. Misoprostol for cervical ripening and labor induction: A meta-analysis
4. Is vaginally administered misoprostol a safe and effective alternative for inducing term labor?
5. A double-blind randomized trial of two dose regimens of misoprostol for cervical ripening and labor induction
6. Misoprostol as a labor induction agent
7. Induction of labor by vaginal misoprostol in patients with previous cesarean delivery
8. Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section
9. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery
10. Uterine rupture during preinduction cervical ripening with misoprostol in a patient with a previous cesarean delivery
11. Misoprostol and pregnancy